BioCentury
ARTICLE | Clinical News

BetaKine TGF-beta-2: Began Phase I/II testing

August 22, 1994 7:00 AM UTC

Celtrix Pharmaceuticals Inc. (CTRX), Santa Clara, Calif. Product: BetaKine TGF-beta-2 recombinant growth factor Indication: Persistent macular edema after cataract removal Status: Began Phase I/II tes...